ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,527Medicare Part D Prescriptions Filled, Including Refills

Rank: 350 out of 2116

$906K Total Retail Price of All Prescriptions

Rank: 185 out of 2116

583 Patients Receiving at Least One Drug in Part D
86% Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Jersey
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 583 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 583 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$106 was the average price of a prescription from this provider, compared to $77 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 322 301 98 1 2
ATORVASTATIN CALCIUM 302 270 91 2 3
LEVOTHYROXINE SODIUM 300 285 84 3 4
LISINOPRIL 256 228 78 4 7
METFORMIN HCL 255 241 78 5 8
METOPROLOL TARTRATE 223 210 73 6 10
FUROSEMIDE 212 195 64 7 6
AMLODIPINE BESYLATE 188 173 57 8 1
HYDROCHLOROTHIAZIDE 185 167 69 9 13
SYNTHROID 182 163 61 10 42
CLONAZEPAM 144 103 39 B 11 57
OMEPRAZOLE 142 120 50 12 5
CARVEDILOL 133 120 33 13 21
CLOPIDOGREL 126 113 35 14 12
ALPRAZOLAM 121 87 34 B 15 14
PREDNISONE 106 88 56 16 55
AZITHROMYCIN 101 84 82 17 35
WARFARIN SODIUM 96 71 16 18 11
CRESTOR 90 75 33 19 18
NAMENDA 86 86 12 20 24
ZOLPIDEM TARTRATE 86 81* 23 20 17
DIOVAN 83 78* 26 22 16
JANUVIA 82 66 34 23 31
NEXIUM 80 69 27 24 20
LOSARTAN POTASSIUM 73 73 22 25 15
RAMIPRIL 73 57 22 25 53
TAMSULOSIN HCL 72 57 23 27 27
GABAPENTIN 69 53 19 28 23
BYSTOLIC 64 59* 17 29 86
LORAZEPAM 64 44 13 B 29 38
VALSARTAN-HYDROCHLOROTHIAZIDE 64 59* 18 29 37
LOVAZA 59 54* 18 32 52
METOPROLOL SUCCINATE 57 52* 22 33 9
BD ULTRA-FINE PEN NEEDLE 56 51* 21 34 138
LANTUS SOLOSTAR 55 41 18 35 70
SYMBICORT 55 50* 15 35 132
OXYCODONE-ACETAMINOPHEN 53 39 26 S2 37 47
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 31, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.